行动能力受损对慢性肢体威胁性缺血患者外周血管介入结局的影响
基于血管质量倡议(VQI)2016年9月至2019年12月49,807例慢性肢体威胁性缺血(CLTI)患者的回顾性研究,比较不同行动能力状态患者接受外周血管内介入后的结局。行动能力受损与30天死亡率显著增加及无截肢生存率显著降低相关,卧床患者30天死亡风险增加6倍,1年无截肢生存率降至不足50%。
要点
- 行动能力受损的CLTI患者介入术后30天死亡风险显著增加。
- 卧床患者30天死亡风险增加6倍,1年无截肢生存率降至47.7%。
- 行动能力状态应在CLTI患者共享决策中予以考虑。
核心结论
- CLTI患者行动能力受损与外周血管内介入后30天死亡率显著增加及无截肢生存率显著降低相关。
- 卧床患者30天死亡风险增加6倍,1年无截肢生存率降至不足50%。
研究设计与样本
- 回顾性研究,纳入血管质量倡议(VQI)2016年9月至2019年12月期间所有接受CLTI治疗的患者。
- 共纳入49,807例患者,其中28,469例(57.2%)行动自如,15,148例(31.0%)需辅助行走,5,395例(10.8%)轮椅依赖,525例(1.1%)卧床。
主要发现
- 与行动自如患者相比,需辅助行走者30天死亡比值比(OR)为2.03(95%CI 1.77-2.34,P<.001),轮椅依赖者OR为2.09(95%CI 1.74-2.51,P<.001),卧床者OR为6.28(95%CI 4.55-8.65,P<.001)。
- 行动自如患者1年内大截肢和死亡风险分别为10%和12%,卧床患者分别高达30%和38%。
- 无截肢生存率从行动自如的81%逐步降至卧床患者的47.7%。
- 与行动自如患者相比,1年内大截肢或死亡风险在需辅助行走者增加35%(HR 1.35,95%CI 1.26-1.44,P<.001),轮椅依赖者增加65%(HR 1.65,95%CI 1.51-1.79,P<.001),卧床者增加2.6倍(HR 2.64,95%CI 2.17-3.21,P<.001)。
- 需辅助行走或卧床患者术后并发症odds显著升高,轮椅依赖患者未见差异。
临床怎么用
- 对于CLTI患者,行动能力状态应纳入外周血管内介入治疗的共享决策过程。
- 卧床CLTI患者介入术后30天死亡风险增加6倍且1年无截肢生存率不足50%,需充分权衡风险与获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Despite prior literature recommending against limb salvage in patients with poor functional status such as nonambulatory patients with chronic limb-threatening ischemia (CLTI), peripheral endovascular interventions continue to be carried out in this group of patients. Clinical outcomes following these interventions are, however, not well-characterized. METHODS: A retrospective review was conducted on all patients treated for CLTI in the Vascular Quality Initiative from September 2016 to December 2019. Logistic regression, Kaplan-Meier survival estimates, log-rank tests, and Cox regression analyses were used as appropriate to study outcomes. The primary outcomes were 30-day mortality and 1-year amputation-free survival. The secondary outcomes were in-hospital death, postoperative complications, 1-year freedom from major amputation, and 2-year survival. RESULTS: Of the 49,807 patients studied, 28,469 (57.2%) were ambulatory, 15,148 (31.0%) were ambulatory with assistance, 5395 (10.8%) were wheelchair bound, and 525 (1.1%) were bedridden. There was a 2-fold increase in the odds of 30-day death in patients who were ambulatory with assistance (odds ratio [OR], 2.03; 95% confidence interval [CI], 1.77-2.34; P < .001) and wheelchair-bound patients (OR, 2.09; 95% CI, 1.74-2.51; P < .001), and a more than 6-fold increase in bedridden patients (OR, 6.28; 95% CI, 4.55-8.65; P < .001) compared with ambulatory patients. There was a significantly higher odds of postoperative complications in patients who were ambulatory with assistance or bedridden, but no difference with wheelchair-bound patients. Among ambulatory patients, the risks of major amputation and death within 1 year were only 10% and 12%, respectively, whereas that of bedridden patients were as high as 30% and 38%, respectively. A stepwise decrease in amputation-free survival from 81% with full ambulatory capacity to less than 50% (47.7%) in bedridden patients was observed. The risk of major amputation or death within 1 year was 35% higher for ambulatory with assistance (hazard ratio [HR], 1.35; 95% CI, 1.26-1.44; P < .001), 65% higher for wheelchair-bound (HR, 1.65; 95% CI, 1.51-1.79; P < .001) and 2.6-fold higher for bedridden (HR, 2.64; 95% CI, 2.17-3.21; P < .001) compared with ambulatory. A similar association was seen for 1-year freedom from major amputation and 2-year survival. CONCLUSIONS: Ambulatory impairment in patients with CLTI is associated with a significant increase in 30-day mortality and significant decrease in amputation-free survival after peripheral endovascular intervention. Bedridden patients had a 6-fold increase in the 30-day death rate, whereas their amputation-free survival dropped to less than 50% at 1 year. These risks should be considered during shared decision-making regarding management options for nonambulatory patients with CLTI.
引用
- Naazie IN, Arhuidese I, Zil-E-Ali A, et al. Impact of impaired ambulatory capacity on the outcomes of peripheral vascular interventions among patients with chronic limb-threating ischemia. J Vasc Surg. 2021. PMID: 33548441. doi:10.1016/j.jvs.2020.12.088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。